BCYRN1 and breast carcinoma: Crucially, it has been shown that increased expression Bcl-xL is associated with high risk of metastasis, reduced sensitivity to chemotherapeutic treatments and poor prognosis,34, 35 implying possible involvement of BC200 as an oncogenic lncRNA during breast cancer progression.